Clinical Trial Update: Safety and Efficacy of Bone Marrow MNC for the Treatment of Cerebral Palsy in Subjects Below 15 Years [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating the safety and efficacy of bone marrow mononuclear cells for cerebral palsy in individuals under 15 years, spanning Phase 2 and Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• Bone Marrow Mononuclear Cells (bone marrow mononuclear cells)

Snippet

Sponsor: Chaitanya Hospital, Pune | Conditions: Cerebral Palsy | Phase 2, Phase 3 | Status: UNKNOWN